日期 | 时间 | 会场 | Session | 角色 | 讲题 |
---|---|---|---|---|---|
2021-10-09 | 15:45-15:55 | 三层水晶A+B |
髓系肿瘤分会场6 |
讲者 | Post-remission measurable residual disease predicts outcome and directs the choice of treatment for patients with intermediate-risk acute myeloid leukemia in CR1 |